Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [mRNA]

ABSTRACT: We analyzed mK562 cells with miR-543 overexpressed or empty vector to determine the mRNA profile of miR-543 overexpressed K562 cells. We used Affymetrix Clariom S Human Array to profile the differentially expressed mRNA in miR-543 overexpressed and control cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE142236 | GEO | 2019/12/18

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [mRNA]

Project description:MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [mRNA]

| PRJNA596275 | ENA

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

Project description:Myelofibrosis (MF) is a myeloproliferative neoplasm characterized by cytopenia and extramedullary hematopoiesis, resulting in splenomegaly. Multiple pathological mechanisms (e.g., circulating cytokines and genetic alterations, such as JAKV617F mutation) have been implicated in the etiology of MF, but the molecular mechanism causing resistance to JAK2V617F inhibitor therapy remains unknown. Among MF patients who were treated with the JAK inhibitor ruxolitinib, we compared noncoding RNA profiles of ruxolitinib therapy responders versus nonresponders and found miR-543 was significantly upregulated in nonresponders. We validated these findings by reverse transcription-quantitative PCR. in this same cohort, in 2 additional independent MF patient cohorts from the United States and Romania, and in a JAK2V617F mouse model of MF. Both in vitro and in vivo models were used to determine the underlying molecular mechanism of miR-543 in MF. Here, we demonstrate that miR-543 targets the dioxygenases ten-eleven translocation 1 (TET1) and 2 (TET2) in patients and in vitro, causing increased levels of global 5-methylcytosine, while decreasing the acetylation of histone 3, STAT3, and tumor protein p53. Mechanistically, we found that activation of STAT3 by JAKs epigenetically controls miR-543 expression via binding the promoter region of miR-543. Furthermore, miR-543 upregulation promotes the expression of genes related to drug metabolism, including CYP3A4, which is involved in ruxolitinib metabolism. Our findings suggest miR-543 as a potentially novel biomarker for the prognosis of MF patients with a high risk of treatment resistance and as a potentially new target for the development of new treatment options.

| S-EPMC7030823 | biostudies-literature

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

Project description: Not available

| S-EPMC10967479 | biostudies-literature

MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

Project description:MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

| PRJNA596276 | ENA

MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [miRNA]

Project description:MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [miRNA]

| PRJNA596272 | ENA

MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2 [miRNA]

Project description:We analyzed 14 patients with Myelofibrosis (MF) to determine the miRNA profile of patients not responding to current MF treatment. We used Affymetrix miRNA-3 array to profile the differentially expressed miRNA in bone-marrow between patients with MF that respond to current MF treatment and the patients with MF that do not respond to current MF treatment.

2019-12-18 | GSE142239 | GEO

MiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-12-18 | GSE142240 | GEO

Sinorhizobium medicae strain:543

Project description:Sinorhizobium medicae 543 Resequencing

| PRJNA499445 | ENA

Fistulifera pelliculosa strain:CCMP 543

Project description:Fistulifera pelliculosa CCMP 543 Nanopore sequencing

| PRJDB12112 | ENA

Colletotrichum trifolii strain:543-2

Project description:Colletotrichum trifolii strain:543-2 Genome sequencing and assembly